Malignant neoplasm of greater curvature of stomach, unspecified
ICD-10 C16.6 is a billable code used to indicate a diagnosis of malignant neoplasm of greater curvature of stomach, unspecified.
C16.6 refers to a malignant neoplasm located on the greater curvature of the stomach, which is the outer curve of the stomach. Gastric cancer, or stomach cancer, is a significant health concern globally, often associated with chronic infection by Helicobacter pylori (H. pylori), a bacterium that can lead to chronic gastritis and is a known risk factor for gastric adenocarcinoma. The disease may present with nonspecific symptoms such as abdominal pain, weight loss, and gastrointestinal bleeding, making early diagnosis challenging. Staging of gastric cancer is crucial for determining treatment options and prognosis, typically classified using the TNM system (Tumor, Node, Metastasis). Treatment often involves surgical intervention, such as gastrectomy, which may be total or partial, depending on the extent of the disease. Postoperative care and monitoring for recurrence are essential components of management. Accurate coding of gastric cancer is vital for appropriate treatment planning and reimbursement.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of gastric cancer, staging evaluations, and treatment planning.
Ensure accurate documentation of tumor characteristics and staging to support coding.
Endoscopy reports, biopsy results, and H. pylori testing.
Evaluation of gastric symptoms, management of H. pylori infection, and surveillance for gastric cancer.
Document any findings related to gastric mucosal changes and H. pylori status.
Used for patients diagnosed with gastric cancer requiring surgical intervention.
Operative reports detailing the procedure and findings.
Oncology specialists should ensure accurate coding of the procedure in relation to the diagnosis.
Common symptoms include abdominal pain, weight loss, nausea, vomiting, and gastrointestinal bleeding. However, many patients may be asymptomatic in the early stages.
Gastric cancer is staged using the TNM system, which assesses the size of the tumor (T), lymph node involvement (N), and the presence of metastasis (M).
H. pylori infection is a significant risk factor for gastric cancer, as it can lead to chronic inflammation and changes in the gastric mucosa that may progress to cancer.
